Hair Regrowth in Alopecia Areata and Re-Pigmentation in Vitiligo in Response to Treatment: Commonalities and Differences

This study examines the mechanisms and treatment responses in alopecia areata (AA) and vitiligo, focusing on hair follicle stem cells (HFSC) and melanocyte stem cells (McSC). It finds that AA lesions regenerate faster than vitiligo lesions due to factors like HFSC abundance and JAK inhibitors' effects. Treatments for AA, such as JAK inhibitors like baricitinib and ritlecitinib, show promise, while vitiligo treatments face challenges, requiring camouflage and psychological support. The study highlights shared pathogenesis through interferon signaling and the potential of targeting stem cell biology and inflammatory pathways to improve outcomes. It also discusses the complexity of vitiligo treatment, including immunomodulators, phototherapy, and surgical options, emphasizing the need for further research to develop novel therapies.